3 completed, 1 unknown. 3 Phase 2, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Unknown 1 |
| Phase 1 | 1 | Unknown 1 |
| Phase 4 | 1 | Completed 1 |
Follow Adrenergic beta-3 Receptor Agonists: new trials by email Literature Review of Adrenergic beta-3 Receptor Agonists trials Research Report on Adrenergic beta-3 Receptor Agonists
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Beta 3 Agonists in Treatment of Non-neurogenic Voiding Dysfunction in Children Beta3-Agonists, Adrenergic, Anticholinergic drug, Solifenacin - Voiding Disorders, Overactive Bladder | Phase 1 / Phase 2 | Unknown | Mansoura University | 70 | 2022-02-01 | 2022-02-15 |
| Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder Anticholinergic, Beta-3 Agonists, Adrenergic, Functional magnetic resonance imaging (fMRI) - Overactive Bladder, Dementia | Phase 4 | Completed | Baylor Research Institute | 12 | 2019-08-05 | 2024-02-02 |
| Beta 3 Agonist Treatment in Heart Failure Mirabegron, Placebo - Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) | Phase 2 | Completed | Henning Bundgaard | 70 | 2013-09-30 | 2020-10-19 |
| Effects of b3-Adrenergic Receptor Agonists on Brown Adipose Tissue beta3-adrenergic receptor agonist - Obesity | Phase 2 | Completed | Aaron Cypess | 15 | 2013-02-01 | 2019-06-11 |
Urinary Bladder, Overactive (2) · Dementia (1) · Lower Urinary Tract Symptoms (1) · Obesity (1) · Urinary Incontinence, Urge (1)
Aaron Cypess (1) · Baylor Research Institute (1) · Henning Bundgaard (1) · Mansoura University (1)
United States (2) · Australia (1) · Denmark (1)
Aaron M Cypess, MD PhD (1) · Henning Bundgaard, MD, PhD, DMSc (1) · Islam Mansour, Mb ChB (1) · Jill Danford, MD (1) · Rachel High, DO (1) · Rose Khavari, MD (1)
PMID 25565203, PMID 27990717, PMID 37160401, PMID 38452283
P30DK036836 (1)